Gal-3 y ST2 como biomarcadores: un paso al frente en el pronóstico de la Insuficiencia Cardíaca

Gal-3 y ST2 como biomarcadores: un paso al frente en el pronóstico de la Insuficiencia Cardíaca

Abstract Aims The American College of Cardiology (ACA)/ American Heart Association (AHA) granted Galectin-3 (Gal-3) and Suppression of Tumorigenicity 2 (ST2) evaluation a class II recommendation for HF prognosis, as an adjunctive to conventional clinical risk factors and natriuretic peptides dosing...

Full description

Bibliographic Details
Main Authors: Mário Barbosa, Andreia Matos, Manuel Bicho
Format: Article
Language:English
Published: Sociedade Galega de Medicina Interna 2000-10-01
Series:Galicia Clínica
Subjects:
acute decompensated heart failure
short-term readmission
short-term mortality
galectin-3
st2
Online Access:https://galiciaclinica.info/publicacion.asp?f=2454

Similar Items

Similar Items